Dark

EYEG
AB Corporate Bond ETF
stock NASDAQ

At Close

Jul 30, 2025

0.00USD0.000%(0.00)12

0.00Bid 0.00Ask 0.00Spread

Pre-market

0.00USD0.000%(0.00)0

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsMore

Headquarters

MA, USA

Industry

Biotechnology

Sep 2, 20250.142

Aug 30, 20191for15reverse

Profile

Eyegate Pharmaceuticals Inc focuses on developing and commercializing products for treating diseases and disorders of the eye.

.dark-mode .qG7vr4{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .qG7vr4{ color: #333333; background-color: white; border: 2px solid #333333; }EYEGAB Corporate Bond ETFstock NASDAQ